Substance use to DSM-5 substance-specific and any substance use disorder in the U.S., 2021–2024
Addictive Behaviors · 2026-11 · 108907
DOI: 10.1016/j.addbeh.2026.108907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addictive Behaviors, 2026-11. Verfasst von Sean Esteban McCabe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States; Survey Research …. Die Arbeit nennt 15 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
OBJECTIVES: To estimate the number of U.S. individuals with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) substance-specific substance use disorder (SUD) versus any DSM-5 SUD across 12 substances and assess SUD severity by polysubstance use. METHODS: This cross-sectional study examined nationally representative data from the National Survey on Drug Use and Health collected annually in U.S. households from 2021 to 2024 among noninstitutionalized individuals aged ≥ 12 years (N = 232,441). Outcomes were DSM-5 substance-specific SUD, any SUD, and SUD severity estimates for individuals who reported past-year use of alcohol, cannabis, crack cocaine, other cocaine, hallucinogens, heroin, inhalants, methamphetamine, prescription opioids, sedatives, stimulants, and tranquilizers. RESULTS: Past-year substance-specific DSM-5 SUD prevalence ranged by substance used (5.2 % for prescription tranquilizers to 79.1 % for heroin). Most people who used substances other than alcohol or cannabis, or misused prescription medications met criteria for any SUD (59.7 % for inhalants to 92.1 % for heroin). Over 75 % of people reporting illicit stimulant use met criteria for any SUD. For past-year hallucinogen use, 5.3 % had a hallucinogen use disorder while 68.3 % had any SUD. Among people with SUD, mild severity was most common with 1-3 substances used (70.8 % for one; 52.7 % for three), while severe SUD was most prevalent among those using ≥ 5 substances (44.4 %). SUD prevalence was higher with polysubstance use versus single-substance use (34.3 % [≈37.2 million] versus 10.5 % [≈10.9 million]). CONCLUSIONS: DSM-5 SUD profiles vary across substances. Findings suggest the need for comprehensive assessment for DSM-5 SUD across all substances, especially with stimulant or polysubstance use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arb…
- Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States; Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States.
- Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States; College of Nursing, Rush University, Chicago, IL, United States.
- Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States.
- Center for the Study of Drugs, Alcohol, Smoking, and Health, University of Michigan School of Nursing, Ann Arbor, MI, United States; Department of Psychology, Texas State University, San Marcos, Texas, United States.
Zitieren
APA
McCabe, S. E., McCabe, V. V., Dickinson, K., Ngo, T. P., & Schepis, T. S. (2026). Substance use to DSM-5 substance-specific and any substance use disorder in the U.S., 2021–2024. Addictive Behaviors, 108907. https://doi.org/10.1016/j.addbeh.2026.108907
Vancouver
McCabe SE, McCabe VV, Dickinson K, Ngo TP, Schepis TS. Substance use to DSM-5 substance-specific and any substance use disorder in the U.S., 2021–2024. Addictive Behaviors. 2026:108907. doi:10.1016/j.addbeh.2026.108907
BibTeX
@article{McCabe2026,
author = {McCabe, Sean Esteban and McCabe, Vita V and Dickinson, Kara and Ngo, Thye Peng and Schepis, Ty S},
title = {Substance use to DSM-5 substance-specific and any substance use disorder in the U.S., 2021–2024},
journal = {Addictive Behaviors},
year = {2026},
pages = {108907},
doi = {10.1016/j.addbeh.2026.108907}
}
EUVIMED